Europe Personalized Nutrition Market Research Report Segmented By Product Type (Active Measurement, Standard Measurement, Functional Foods & Beverages, Dietary Supplements & Nutraceuticals, Sports Nutrigenomics, Digitized DNA-Based Diet Routines), Application, End user, Form, & Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic & Rest of Europe) - Industry Analysis on Size, Share, Trends & Growth Forecast (2026 to 2034)
The size of the Europe personalized nutrition market was calculated to be USD 3.69 billion in 2025 and is anticipated to be worth USD 12.63 billion by 2034, from USD 4.23 billion in 2026, growing at a CAGR of 14.65% during the forecast period.
Personalized nutrition (PN) is a scientific field that uses individual-specific data to develop targeted dietary advice, products, or services. It departs from the traditional "one-diet-fits-all" approach by recognizing that differences in genetics, metabolism, and lifestyle cause people to respond differently to the same foods. This market is not merely a commercial trend but a convergence of advanced diagnostics, digital health, and nutritional science aimed at preventing chronic disease and optimizing well-being. Its current evolution is deeply intertwined with Europe’s public health priorities and regulatory landscape. According to the World Health Organization’s European regional office, over 50 percent of the EU population is overweight or obese, and non-communicable diseases account for 80 percent of all deaths, creating a powerful impetus for preventive, individualized health solutions. Simultaneously, as per the European Commission’s Directorate General for Health and Food Safety, there is growing recognition that traditional population-wide dietary guidelines are insufficient for addressing the complex interplay of biological and behavioral factors that influence health outcomes. This context positions personalized nutrition as a critical tool in the EU’s strategy to move toward a more predictive, preventive, and participatory model of healthcare.
The escalating burden of chronic metabolic disorders, such as type 2 diabetes, cardiovascular disease, and obesity, is directly linked to diet and lifestyle, which is pushing forward the growth of the Europe personalized nutrition market. Rising disease burdens are straining public budgets and reducing quality of life, driving a major shift toward preventative, consumer-focused healthcare. Personalized nutrition offers a scientifically grounded approach to mitigate individual risk by tailoring dietary interventions to a person’s specific metabolic response to food. For instance, continuous glucose monitoring has revealed that individuals have vastly different glycemic responses to the same meal, a finding that undermines generic dietary advice. Updated dietary guidance from European diabetes specialists highlights that tailoring nutritional education to an individual's specific needs is more effective at managing blood sugar levels than following generic dietary advice. Recent evidence emphasizes that personalized dietary education significantly improves glycemic control, departing from a one-size-fits-all approach. This evidence-based efficacy, coupled with the EU’s focus on reducing the economic burden of chronic disease, is creating a robust demand for services that translate complex biological data into actionable, individualized eating plans.
The rapid democratization of technologies accelerates the expansion of the Europe personalized nutrition market. These technologies are now accessible to a mainstream audience. The cost of genomic sequencing has plummeted, and at-home test kits for analyzing gut microbiome composition or metabolic markers are now widely available. These diagnostics are increasingly integrated with user-friendly digital platforms that use artificial intelligence to interpret results and generate customized meal plans, supplement recommendations, and real-time feedback. The market for digital health applications delivering individualized dietary planning has experienced substantial expansion in recent years, driven by a growing proactive interest in personal wellness. Modern platforms are increasingly integrating biological data, such as genetic and microbiome profiling, to provide more precise, personalized nutritional guidance. This seamless integration of testing, data analytics, and digital coaching creates a compelling user experience that empowers individuals to take control of their health. The convenience and perceived scientific authority of these integrated platforms are key factors driving mass market adoption beyond the early adopter niche.
Intricate and often unclear regulatory environment governing both health-related claims and the handling of sensitive personal data acts as a restraint on the Europe personalized nutrition market. The European Union’s Nutrition and Health Claims Regulation (EC) No 1924/2006 strictly controls the language companies can use to describe the benefits of their products, and obtaining approval for novel, personalized claims is a costly and uncertain process. Simultaneously, the General Data Protection Regulation imposes stringent requirements on the collection, storage, and processing of highly sensitive genetic and health data. Recent assessments emphasize that stringent compliance requirements for food health claims impose substantial financial burdens and legal risks, potentially hindering product development for companies of all sizes, prompting calls for more efficient, modern regulatory approaches. Many companies operate in a gray area, which deters investment and confuses consumers about the legitimacy and safety of personalized nutrition offerings.
The near-universal lack of public or private health insurance reimbursement for personalized nutrition services also hampers the expansion of the Europe personalized nutrition market. Consequently, this relegates them to a discretionary, out-of-pocket expense. A comprehensive personalized nutrition program, including testing, consultation, and ongoing support, can easily cost several hundred euros, a price point that excludes a large segment of the population. According to a study, European consumers show significant interest in tailored health solutions, such as personalized nutrition, though high costs and inflationary pressures make them feel like discretionary expenses. Despite cost barriers, many consumers are willing to share personal nutritional data to achieve better health outcomes. This affordability gap means that the most effective preventive health tool remains inaccessible to those who might benefit from it the most, particularly lower-income groups who are disproportionately affected by diet-related chronic diseases. Access to these services will remain restricted to a wealthy minority until they are formally integrated into insurance reimbursement frameworks, thereby stalling progress toward population health objectives.
The strategic partnership between personalized nutrition providers and corporations seeks to improve employee health and reduce healthcare costs, and thereby constitutes a major growth opportunity for the Europe personalized nutrition market. Employers across Europe are increasingly investing in comprehensive wellness programs as a tool to boost productivity, reduce absenteeism, and manage rising insurance premiums. Personalized nutrition, with its strong evidence base for preventing and managing chronic conditions, is a natural fit for these initiatives. Current evidence from international occupational health research indicates that organizations implementing comprehensive wellness initiatives typically experience a notable decrease in employee absenteeism and a substantial improvement in overall workforce commitment. Personalized nutrition firms can scale and stabilize revenue by adopting a B2B2C model, which grants them access to large employee groups while overcoming individual cost barriers and integrating their tech into corporate wellness cultures.
The expansion of personalized nutrition into the clinical realm as a formal medical nutrition therapy for patients with specific diagnosed conditions is another potential prospect for the Europe personalized nutrition market. This moves the service from a wellness product to a prescribed therapeutic intervention, which can be delivered in collaboration with dietitians, doctors, and hospitals. There is a growing body of clinical evidence supporting the use of tailored diets for managing conditions like irritable bowel syndrome, phenylketonuria, and certain types of cancer. As per the European Society for Clinical Nutrition and Metabolism, incorporating customized nutrition strategies directly into standard patient care routines can enhance treatment results and improve patient quality of life. This clinical validation paves the way for future reimbursement by national health services and creates a high-trust, high-value channel for personalized nutrition providers who can meet the rigorous standards of the medical community.
The gap between the bold promises of commercial providers and the robust, long-term scientific evidence required to validate their efficacy is a serious challenge to the Europe personalized nutrition market. While short-term studies show promise, there is a lack of large-scale, longitudinal randomized controlled trials that definitively prove personalized diets lead to better health outcomes than general healthy eating advice over many years. This evidence gap fuels consumer skepticism and criticism from the scientific community. As per a study, many commercial algorithms are proprietary “black boxes” with no peer-reviewed validation, making it impossible for independent scientists to assess their accuracy. This lack of transparency and rigorous proof makes it difficult for consumers to discern credible services from pseudoscience, damaging the reputation of the entire sector and hindering mainstream acceptance and trust.
Profound ethical dilemmas surrounding the collection and use of highly sensitive personal data, particularly genetic information, further hinder the expansion of the Europe personalized nutrition market. Consumers are rightly concerned about how their data will be used, stored, and potentially shared with third parties, including insurers or employers. The fear of genetic discrimination, where an individual’s genetic predisposition to a disease could affect their ability to obtain insurance or employment, is a serious barrier to adoption. Although the EU has strong data protection laws, the rapid pace of technological innovation often outstrips regulatory oversight. As per research, there is an urgent need for clear ethical guidelines specific to nutrigenomics to ensure informed consent and prevent misuse. The widespread adoption and social impact of personalized nutrition services will be limited until ethical concerns are mitigated by transparent operations and stringent, enforceable legal standards.
| REPORT METRIC | DETAILS |
| Market Size Available | 2025 to 2034 |
| Base Year | 2025 |
| Forecast Period | 2026 to 2034 |
| CAGR | 14.65% |
| Segments Covered | By Product Type, Application, End Use, And Region |
| Various Analyses Covered | Global, Regional & Country Level Analysis; Segment-Level Analysis; DROC, PESTLE Analysis; Porter’s Five Forces Analysis; Competitive Landscape; Analyst Overview of Investment Opportunities |
| Regions Covered | UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, and the Czech Republic |
| Market Leaders Profiled | Amway, BASF, DSM, Herbalife Nutrition Ltd, DNAfit, Nutrigenomix, Zipongo, Viome, Habit, and Atlas Biomed Group Limited. |
The dietary supplements and nutraceuticals segment held the majority share of 35.6% of the Europe personalized nutrition market in 2025. The supremacy of the dietary supplements and nutraceuticals segment is driven by its role as the most accessible and scalable delivery mechanism for personalized health interventions. Moreover, this segment is backed by the well-established regulatory pathway for supplements under the EU’s Food Supplements Directive, which allows for a faster and more predictable route to market compared to novel foods or medical devices. Consumers are highly familiar with the supplement format, making it an easy entry point for personalized regimens. According to the European Federation of Associations of Health Product Manufacturers, a significant portion of the adult population in Western Europe is adopting proactive health measures by regularly incorporating dietary supplements into their diets. Personalized vitamin and mineral packs, tailored to an individual’s genetic predispositions or blood biomarkers, leverage this existing habit while adding a layer of scientific customization. This combination of regulatory clarity, consumer familiarity, and ease of e-commerce fulfillment has solidified supplements as the foundational product type in the personalized nutrition ecosystem.
The digitized DNA-based diet routines segment is predicted to witness the highest CAGR of 21.4% from 2026 to 2024 due to the convergence of affordable direct-to-consumer genetic testing and sophisticated digital platforms that translate complex genomic data into simple, actionable dietary advice. A key driver is the increasing consumer curiosity about their own biology and a desire for a scientific basis for their food choices. According to research, personal genomic testing is seeing increased uptake across the continent, creating a larger population interested in follow-on health and heritage insights. Companies in this space are moving beyond generic ancestry reports to offer detailed insights into nutrient metabolism, food sensitivities, and optimal macronutrient ratios. The seamless user experience, order a kit online, receive a personalized meal plan via an app, lowers the barrier to entry and creates a powerful engagement loop that keeps users invested in their long term health journey, making this the most dynamic frontier of the market.
In 2025, the weight management application segment was the largest segment in the Europe personalized nutrition market, capturing a share of 30.6%. The prominence of the weight management segment is attributed to the pervasive public health challenge of overweight and obesity across Europe, which creates a massive and sustained consumer demand for effective solutions. Beyond the first point, this segment also sees the growing understanding that a universal “one size fits all” diet is ineffective, as individuals have unique metabolic responses to food that influence weight gain and loss. Personalized nutrition offers a scientifically grounded alternative by tailoring calorie intake, macronutrient balance, and meal timing to an individual’s specific biology and lifestyle. According to the World Health Organization’s European regional office, the majority of the adult population in the EU is living with overweight or obesity, establishing a rapidly expanding, significant addressable market for health and wellness interventions. The emotional and social drivers behind weight loss, combined with the promise of a more effective, customized approach, ensure that weight management remains the single largest application area for personalized nutrition services.
The metabolic health application segment is estimated to register the fastest CAGR of 19.8% during the forecast period, owing to the rising prevalence of pre diabetes, insulin resistance, and metabolic syndrome, conditions that are often silent but are major precursors to type 2 diabetes and cardiovascular disease. A key driver is the advent of affordable continuous glucose monitors that allow individuals to see in real time how their body responds to different foods, providing immediate, personalized feedback. The World Health Organization (WHO) European Regional Office indicates that a majority of the adult population across the region is living with overweight or obesity, establishing a rapidly expanding, significant, and urgent addressable market for health and wellness interventions. Personalized nutrition programs that use this data to create stable blood sugar profiles are proving highly effective, with clinical studies showing significant improvements in HbA1c levels. This focus on early intervention and prevention, backed by tangible data, is transforming metabolic health from a clinical concern into a proactive, consumer-driven wellness goal, fueling rapid market expansion.
The direct-to-consumer segment dominated the Europe personalized nutrition market by accounting for a 55.1% share in 2025. The dominance of the direct-to-customer segment is credited to the perfect alignment of the DTC model with the core principles of personalized nutrition: empowerment, convenience, and personal control over one’s health journey. A new factor pushing this segment is the ability of DTC companies to leverage digital marketing, e-commerce, and mobile apps to reach a broad audience without the gatekeeping of traditional healthcare channels. Consumers can easily order a test kit online, receive their results, and get a customized plan delivered directly to their phone, all on their own terms. According to various sources, direct-to-consumer (DTC) brands dominate the European personalized nutrition sector, with at-home testing and digital tools serving as the primary entry point for consumers. This trend reflects a strong shift towards customized, app-based health solutions and subscription supplements within the region. This model’s low friction, high scalability, and strong focus on user experience have made it the primary engine of market growth and consumer adoption across the continent.
The hospitals and clinics segment is anticipated to witness the fastest CAGR of 18.5% from 2026 to 2034. This rapid growth is fueled by the gradual integration of personalized nutrition into formal medical care pathways as a recognized therapeutic tool. In addition, this segment is helped by the mounting clinical evidence supporting the use of tailored dietary interventions for managing chronic diseases like diabetes, cardiovascular disease, and certain cancers. As per the European Society for Clinical Nutrition and Metabolism, hospitals across Europe are increasingly integrating evidence-based, personalized dietary counseling into patient care to improve nutritional status and enhance clinical outcomes. This shift from wellness to medicine lends the field greater credibility and opens the door to future reimbursement by national health services. The involvement of trusted healthcare professionals also addresses consumer skepticism, creating a high-trust, high-impact channel that is poised for significant expansion as the line between nutrition and medicine continues to blur.
Germany led the European personalized nutrition market by accounting for a 20.4% share in 2025. The dominance of the German market is driven by a highly health-conscious population, a robust digital health infrastructure, and a strong tradition of preventive medicine. A further key accelerator is the country’s pioneering “Digital Health Applications” (DiGA) framework, which allows certain digital health tools, including personalized nutrition platforms, to be prescribed by doctors and reimbursed by statutory health insurance. According to the German Federal Institute for Drugs and Medical Devices (BfArM), a steadily increasing number of digital health apps have been approved since the launch of the Digitale Gesundheitsanwendung (DiGA) scheme, establishing a pioneering, fast-track pathway for app reimbursement that has set a global standard for integrating digital therapeutics into mainstream healthcare. The presence of world-class research institutions and a large base of tech-savvy consumers further fosters a fertile environment for innovation and adoption, making Germany the most advanced and policy-supportive market in Europe.
The United Kingdom was the second largest country in the Europe personalized nutrition market by capturing a share of 18.3% in 2025. The expansion of the UK market is also propelled by a dynamic startup ecosystem and a National Health Service increasingly focused on prevention. The UK’s market is also driven by a strong culture of entrepreneurship in the digital health space, with London serving as a hub for personalized nutrition innovators. The UK national health service is actively incorporating digital health applications, wearable technology, and virtual platforms into its national strategy to support individuals with obesity and Type 2 diabetes, driven by a policy shift aimed at increasing access to, and adoption of, remote, technology-enabled care. The country’s high internet penetration and consumer willingness to adopt new health technologies provide a ready-made audience. Furthermore, the UK’s departure from the EU has allowed for a more agile regulatory approach to novel health claims, enabling faster market entry for innovative services, positioning the UK as a key launchpad for new personalized nutrition models.
France is another key player in the Europe personalized nutrition market due to its strong emphasis on culinary heritage and a growing interest in the science of “eating well.” The French market is also fueled by a national paradox: a deep love for food coexisting with a rising concern about diet-related health issues. A key driver is the government’s “National Nutrition and Health Program,” which has begun to explore personalized approaches to combat obesity and metabolic disease. According to sources, a significant portion of adults are now overweight, creating a powerful impetus for new solutions. The French consumer is particularly receptive to services that respect their gastronomic culture while offering scientific guidance, favoring platforms that integrate seamlessly with local cuisine rather than imposing foreign diets. This unique cultural context makes France a sophisticated and discerning market that values both science and sensory pleasure.
The Netherlands grew steadily in the Europe personalized nutrition market owing to world-leading life science and health technology sectors, and a collaborative ecosystem where startups, universities like Wageningen, and major food and pharma companies work together on personalized nutrition research. As per research, the government actively supports public-private partnerships in this field, recognizing its potential for improving public health and economic growth. The country’s high digital literacy and universal health coverage create an ideal testing ground for integrated health models. The Dutch consumer is highly pragmatic and evidence-oriented, demanding clear proof of efficacy, which drives companies to invest in robust clinical validation, making the Netherlands a critical market for establishing scientific credibility.
Sweden is likely to expand notably in the Europe personalized nutrition market over the forecast period and stands out for its exceptionally high levels of digital adoption and a strong societal focus on preventive health and sustainability. The Swedish market is supported by a population that is early to adopt new health technologies and trusts public health authorities. An additional driver is the national “Food Strategy,” which encourages personalized and sustainable eating patterns. According to various sources, a large share of the population uses the internet daily, and there is a high level of engagement with digital public health services. The Swedish consumer is also highly sensitive to environmental impact, favoring personalized nutrition services that promote plant-based and locally sourced eating. This combination of digital readiness, trust in science, and ethical consumption makes Sweden a forward-looking and influential market that often sets trends for the wider Nordic region.
The competitive landscape of the Europe personalized nutrition market is highly fragmented, featuring a dynamic mix of multinational nutrition giants, agile health tech startups, and specialized diagnostic firms. Competition is intensifying around scientific credibility, data privacy, and seamless user experience rather than just product formulation. Large players like Nestlé leverage their brand trust and R and D scale to offer integrated solutions, while startups like DayTwo compete on cutting-edge science and niche applications such as microbiome or DNA-based diets. A key battleground is the ability to navigate the EU’s complex regulatory environment for health claims and data protection, which creates a high barrier to entry and favors companies with strong legal and compliance capabilities. The market is also seeing consolidation as larger firms acquire innovative tech platforms to bolster their personalization engines. Ultimately, success hinges on the ability to translate complex biological data into simple, trustworthy, and culturally relevant dietary advice that delivers measurable health outcomes, fostering a competitive environment where scientific rigor and consumer empathy are paramount.
A few major players of the Europe personalized nutrition market include
Key players in the Europe personalized nutrition market are primarily focused on three strategic pillars to drive growth and credibility. First, they are integrating advanced diagnostics like genomics and microbiome analysis with digital platforms to deliver highly tailored and actionable nutrition plans. Second, they are forging strategic partnerships with healthcare providers, hospitals, and corporate wellness programs to move beyond direct-to-consumer models and gain clinical validation. Third, they are investing in robust scientific research and localizing their offerings to comply with EU regulations and meet the specific cultural and dietary preferences of diverse European consumers. These strategies collectively address the core challenges of scientific legitimacy, regulatory compliance, and consumer trust, which are essential for long term success in this complex and evolving market.
This research report on the Europe personalized nutrition market has been segmented and sub-segmented based on product type, application, end use, and region.
By Product Type
By Application
By End Use
By Region
Frequently Asked Questions
Market growth is driven by increasing health awareness, rising prevalence of lifestyle-related diseases, growing adoption of wearable devices, advancements in genetic testing, and rising consumer demand for customized health solutions.
The market includes customized dietary supplements, DNA-based diet plans, personalized protein powders, functional beverages, meal subscription services, and mobile applications that provide nutrition guidance based on individual data.
Technology plays a crucial role through AI-driven diet planning, genetic testing kits, microbiome analysis, mobile health apps, and wearable fitness trackers. These tools help collect personal health data and deliver tailored dietary recommendations.
Primary consumers include health-conscious individuals, athletes, aging populations, individuals managing chronic conditions, and tech-savvy millennials seeking customized wellness solutions.
Challenges include high product costs, data privacy concerns, strict EU regulations related to health claims, limited consumer trust in genetically-based recommendations, and the need for scientific validation.
Regulatory compliance is critical in Europe due to strict food safety and health claim regulations under EU law. Companies must ensure transparency, scientific backing, and compliance with data protection rules such as GDPR.
Products and services are primarily distributed through direct-to-consumer online platforms, subscription models, specialty health stores, pharmacies, and partnerships with healthcare providers.
Sustainability is increasingly important, with consumers preferring plant-based, locally sourced, and eco-friendly packaged personalized products. Many companies focus on clean-label and sustainable ingredient sourcing.
The market is expected to grow significantly over the coming years, supported by technological advancements, increasing digitalization in healthcare, and a shift toward preventive healthcare. Continuous innovation in AI, genomics, and data analytics is likely to drive long-term expansion.
Germany, the United Kingdom, France, and the Netherlands are among the leading markets due to strong digital health infrastructure, higher consumer awareness, and advanced healthcare systems.
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from
$ 2000
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: sales@marketdataforecast.com
Reports By Region